Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Impact of Daridorexant on Sleep, Daytime Alertness, and SmokingChemically-Induced Disorders, Dyssomnias, Sleep Disorders, Intrinsic, Substance Use Disorders, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder, substance-related disorderNot yet recruitingPhase 42026-01-09NCT07328594

2 results · Page 1 of 1

Swipe the table sideways for more columns.

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Legacy Research InstitutePortlandUnited States2